Asia-pacific Epilepsy Devices Market 2022-2028
MARKET OUTLOOK
Triton Market Research’s report infers that the Asia-Pacific epilepsy devices market is expected to showcase a CAGR of 8.38% during the forecast years 2022-2028. Japan, China, India, ASEAN countries, Australia & New Zealand, South Korea, and Rest of Asia-Pacific are examined in the given region.
Japan provides a low-cost national health insurance system that is available to everyone. In this regard, several large hospitals offer a full range of medical services. Epilepsy procedures are undertaken in high volume owing to the robust local epileptic network. Considering these factors, epilepsy services are in high demand. And this trend is expected to remain over the forecast period due to a rise in patient visits to hospitals, clinics, and care facilities.
In South Korea, there is a high prevalence of epilepsy among the older population. Moreover, the rise in chronic CNS diseases is expected to surge the number of patients diagnosed with epilepsy, creating a treatment gap. In this regard, the introduction of the health insurance review and assessment (HIRA) system helps easily access information about diagnoses and medical services. Besides, the system pays for medical expenses incurred during epilepsy treatment. Therefore, such steps by the government are likely to boost the epilepsy devices market.
COMPETITIVE OUTLOOK
The key companies in the epilepsy devices market consist of Cadwell Industries Inc, Medtronic Plc, Boston Scientific Corporation, Empatica Inc, Natus Medical Incorporated, and Neurosoft.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook